CureVac
Julia Bosch is a seasoned professional in regulatory affairs, currently serving as Senior Manager at CureVac since October 2022. Previously, Julia held the position of Principal Regulatory Lead at Syneos Health from January 2018 to September 2022, where responsibilities included global regulatory oversight for complex clinical studies, budget management, and mentoring junior team members. Julia's earlier roles included Senior Site Start Up and Regulatory Specialist, Site Start Up and Regulatory Specialist, and Clinical Research Associate at INC Research, along with an internship and a role as Research Associate at the José Carreras Cord Blood Bank. Julia holds a PhD in Molecular Biology and a Diploma in Biology from the University of Düsseldorf.
This person is not in the org chart
This person is not in any offices
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.